Group | Frequentist Modelling

Students attending a course in statistics

The group operates the data centre of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA). It develops models for studying the long-term effects of air pollution on population health, and supports and supervises analyses conducted within SAPALDIA.

The group conducts time-series modelling of the short-term effects of air pollution and also contributes to the development of spatio-temporal models of air pollutants in Switzerland. Moreover, the group is linked to clinical research projects, notably in neurology, and specialised in supporting clinically oriented projects within the Swiss TPH data team. The group runs statistics courses for the medical curriculum and administers two master level courses in the Faculty of Science and in two postgraduate courses.

Latest Publications

All Publications

Brown J.A et al. Dolutegravir in real life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho. HIV Med. 2023;24(2):153-162. DOI: 10.1111/hiv.13352

Kopo M et al. Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: the PEBRA cluster-randomized trial. PLoS Med. 2023;20(1):e1004150. DOI: 10.1371/journal.pmed.1004150

Labhardt N.D et al. Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho. PLoS One. 2023;18(3):e0278653. DOI: 10.1371/journal.pone.0278653

Mnzava D et al. Decentralization of viral load testing to improve HIV care and treatment cascade in rural Tanzania: observational study from the Kilombero and Ulanga Antiretroviral Cohort. BMC Infect Dis. 2023;23:222. DOI: 10.1186/s12879-023-08155-6

Seiler O et al. HIV care preferences among young people living with HIV in Lesotho: a secondary data analysis of the PEBRA cluster randomized trial. AIDS Res Treat. 2023;2023:8124192. DOI: 10.1155/2023/8124192